ASIA: +91 96043 17127 | USA: 1 (347) 690-0211 | Translate : 

Covid-19

Neuromodulation Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

report img

Neuromodulation Market By Technology (Internal Neuromodulation and External Neuromodulation), By Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine, and Others), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Neuromodulation industry. The report analyzes and declares the historical and current trends analysis of the Neuromodulation industry and subsequently recommends the projected trends anticipated to be observed in the global Neuromodulation market during the upcoming years.

The global Neuromodulation market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Neuromodulation market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Billion) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Neuromodulation industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Neuromodulation industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the global Neuromodulation market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Neuromodulation industry. The global Neuromodulation market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Neuromodulation sector. Key strategic developments in the global Neuromodulation market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the global Neuromodulation market are appropriately highlighted in the report.

Neurological disorders such as Alzheimer's disease, epilepsy, and Parkinson's disease generally affect the central and peripheral nervous system. There are certain neurological disorders that are caused by bacterial, viral, and fungal infections as well. Thus, there is an urgent need for neuromodulation technologies to manage such disorders by using small electrodes & pulse generators to produce electrical stimulations to supplement neurological activities in subjects.

The key drivers of the global Neuromodulation market are the growing prevalence of neurological disorders and the increasing ongoing research or R&D activities for increasing the application of neuromodulation. Additionally, the growing awareness among the people regarding neurodegenerative disorders helps increase the demand for neuromodulation technologies across the globe. However, the expense of neuromodulation procedures and equipment, the stringent approval policies, and demand for the expert workforce are likely to hinder the global Neuromodulation market growth. The growing geriatric population across the globe increases the number of neurological disorders such as Alzheimer’s and Parkinson’s diseases and the surging awareness regarding the safety and efficacy of neurostimulator devices will further supplement the market growth.

The global Neuromodulation market research report delivers an acute valuation and taxonomy of the Neuromodulation industry by practically splitting the market on the basis of different technology, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Neuromodulation industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Neuromodulation industry is provided for the leading economies of the world.

The global Neuromodulation market is segmented based on Technology and Application. By technology, the global Neuromodulation market is divided into Internal Neuromodulation and External Neuromodulation. Based on application, the Neuromodulation market is segregated into Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Urinary, and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine, and Others.

Some of the essential players operating in the global Neuromodulation market, but not restricted to include Boston Scientific Corporation, Medtronic, Abbott, Synapse Biomedical, Inc., LivaNova, Nevro Corporation, NeuroPace, NeuroSigma, Neuronetics, and BioControl Medical

logoThe taxonomy of the Neuromodulation industry by its scope and segmentation is as follows:

logoGlobal Neuromodulation Market: Technology Segmentation Analysis

  • Internal Neuromodulation
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Respiratory Electrical Stimulation (RES)

logoGlobal Neuromodulation Market: Application Segmentation Analysis

  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Obsessive-Compulsive Disorder
  • Migraine
  • Others

logoGlobal Neuromodulation Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Neuromodulation market – Technology Analysis
    1. 2.1. Global Neuromodulation Market – Technology Overview
    2. 2.2. Global Neuromodulation Market Share, by Technology, 2018 & 2025 (USD Billion)
    3. 2.3. Internal Neuromodulation
      1. 2.3.1. Global Internal Neuromodulation Neuromodulation Market, 2016-2026 (USD Billion)
    4. 2.4. External Neuromodulation
      1. 2.4.1. Global External Neuromodulation Neuromodulation Market, 2016-2026 (USD Billion)
  3. CHAPTER 3. Neuromodulation market – Application Analysis
    1. 3.1. Global Neuromodulation Market – Application Overview
    2. 3.2. Global Neuromodulation Market Share, by Application, 2018 & 2025 (USD Billion)
    3. 3.3. Chronic Pain Management
      1. 3.3.1. Global Chronic Pain Management Neuromodulation Market, 2016-2026 (USD Billion)
    4. 3.4. Failed back syndrome
      1. 3.4.1. Global Failed back syndrome Neuromodulation Market, 2016-2026 (USD Billion)
    5. 3.5. Epilepsy
      1. 3.5.1. Global Epilepsy Neuromodulation Market, 2016-2026 (USD Billion)
    6. 3.6. Tremor
      1. 3.6.1. Global Tremor Neuromodulation Market, 2016-2026 (USD Billion)
    7. 3.7. Urinary and Fecal Incontinence
      1. 3.7.1. Global Urinary and Fecal Incontinence Neuromodulation Market, 2016-2026 (USD Billion)
    8. 3.8. Dystonia
      1. 3.8.1. Global Dystonia Neuromodulation Market, 2016-2026 (USD Billion)
    9. 3.9. Gastroparesis
      1. 3.9.1. Global Gastroparesis Neuromodulation Market, 2016-2026 (USD Billion)
    10. 3.10. Parkinson's Disease
      1. 3.10.1. Global Parkinson's Disease Neuromodulation Market, 2016-2026 (USD Billion)
    11. 3.11. Obsessive-Compulsive Disorder
      1. 3.11.1. Global Obsessive-Compulsive Disorder Neuromodulation Market, 2016-2026 (USD Billion)
    12. 3.12. Migraine
      1. 3.12.1. Global Migraine Neuromodulation Market, 2016-2026 (USD Billion)
    13. 3.13. Others
      1. 3.13.1. Global Others Neuromodulation Market, 2016-2026 (USD Billion)
  4. CHAPTER 4. Neuromodulation market – Regional Analysis
    1. 4.1. Global Neuromodulation Market Regional Overview
    2. 4.2. Global Neuromodulation Market Share, by Region, 2018 & 2025 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Neuromodulation Market size and forecast, 2016-2026
      2. 4.3.2. North America Neuromodulation Market, by Country, 2018 & 2025 (USD Billion)
      3. 4.3.3. North America Neuromodulation Market, by Technology, 2016-2026
        1. 4.3.3.1. North America Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
      4. 4.3.4. North America Neuromodulation Market, by Application, 2016-2026
        1. 4.3.4.1. North America Neuromodulation Market, by Application, 2016-2026 (USD Billion)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Billion)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Billion)
    4. 4.4. Europe
      1. 4.4.1. Europe Neuromodulation Market size and forecast, 2016-2026
      2. 4.4.2. Europe Neuromodulation Market, by Country, 2018 & 2025 (USD Billion)
      3. 4.4.3. Europe Neuromodulation Market, by Technology, 2016-2026
        1. 4.4.3.1. Europe Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
      4. 4.4.4. Europe Neuromodulation Market, by Application, 2016-2026
        1. 4.4.4.1. Europe Neuromodulation Market, by Application, 2016-2026 (USD Billion)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Billion)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Billion)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Billion)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Billion)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Billion)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Billion)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Neuromodulation Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Neuromodulation Market, by Country, 2018 & 2025 (USD Billion)
      3. 4.5.3. Asia Pacific Neuromodulation Market, by Technology, 2016-2026
        1. 4.5.3.1. Asia Pacific Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
      4. 4.5.4. Asia Pacific Neuromodulation Market, by Application, 2016-2026
        1. 4.5.4.1. Asia Pacific Neuromodulation Market, by Application, 2016-2026 (USD Billion)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Billion)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Billion)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Billion)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Billion)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Billion)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Billion)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Neuromodulation Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Neuromodulation Market, by Country, 2018 & 2025 (USD Billion)
      3. 4.6.3. Latin America Neuromodulation Market, by Technology, 2016-2026
        1. 4.6.3.1. Latin America Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
      4. 4.6.4. Latin America Neuromodulation Market, by Application, 2016-2026
        1. 4.6.4.1. Latin America Neuromodulation Market, by Application, 2016-2026 (USD Billion)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Billion)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Billion)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Billion)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Neuromodulation Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Neuromodulation Market, by Country, 2018 & 2025 (USD Billion)
      3. 4.7.3. The Middle-East and Africa Neuromodulation Market, by Technology, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
      4. 4.7.4. The Middle-East and Africa Neuromodulation Market, by Application, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Neuromodulation Market, by Application, 2016-2026 (USD Billion)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Billion)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Billion)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Billion)
  5. CHAPTER 5. Neuromodulation market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Boston Scientific Corporation
      1. 6.1.1. Company Overview
      2. 6.1.2. Boston Scientific Corporation Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Medtronic
      1. 6.2.1. Company Overview
      2. 6.2.2. Medtronic Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Abbott
      1. 6.3.1. Company Overview
      2. 6.3.2. Abbott Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Synapse Biomedical Inc.
      1. 6.4.1. Company Overview
      2. 6.4.2. Synapse Biomedical Inc. Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. LivaNova
      1. 6.5.1. Company Overview
      2. 6.5.2. LivaNova Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Nevro Corporation
      1. 6.6.1. Company Overview
      2. 6.6.2. Nevro Corporation Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. NeuroPace
      1. 6.7.1. Company Overview
      2. 6.7.2. NeuroPace Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. NeuroSigma
      1. 6.8.1. Company Overview
      2. 6.8.2. NeuroSigma Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Neuronetics
      1. 6.9.1. Company Overview
      2. 6.9.2. Neuronetics Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. BioControl Medical
      1. 6.10.1. Company Overview
      2. 6.10.2. BioControl Medical Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Neuromodulation — Industry Analysis
    1. 7.1. Neuromodulation Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Neuromodulation Market – Attractiveness Analysis
      1. 7.4.1. By Technology
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 2 Global Neuromodulation Market Share, by Technology, 2018 & 2025 (USD Billion)
        FIG. 3 Global Internal Neuromodulation Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 4 Global External Neuromodulation Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 5 Global Neuromodulation Market Share, by Application, 2018 & 2025 (USD Billion)
        FIG. 6 Global Chronic Pain Management Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 7 Global Failed back syndrome Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 8 Global Epilepsy Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 9 Global Tremor Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 10 Global Urinary and Fecal Incontinence Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 11 Global Dystonia Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 12 Global Gastroparesis Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 13 Global Parkinson's Disease Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 14 Global Obsessive-Compulsive Disorder Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 15 Global Migraine Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 16 Global Others Neuromodulation Market, 2016-2026 (USD Billion)
        FIG. 17 Global Neuromodulation Market Share, by Region, 2018 & 2025
        FIG. 18 North America Neuromodulation Market, 2016-2026
        FIG. 19 U.S. Neuromodulation Market, 2016-2026
        FIG. 20 Canada Neuromodulation Market, 2016-2026
        FIG. 21 Europe Neuromodulation Market, 2016-2026
        FIG. 22 Germany Neuromodulation Market, 2016-2026
        FIG. 23 France Neuromodulation Market, 2016-2026
        FIG. 24 U.K. Neuromodulation Market, 2016-2026
        FIG. 25 Italy Neuromodulation Market, 2016-2026
        FIG. 26 Spain Neuromodulation Market, 2016-2026
        FIG. 27 Rest of Europe Neuromodulation Market, 2016-2026
        FIG. 28 Asia Pacific Neuromodulation Market, 2016-2026
        FIG. 29 China Neuromodulation Market, 2016-2026
        FIG. 30 Japan Neuromodulation Market, 2016-2026
        FIG. 31 India Neuromodulation Market, 2016-2026
        FIG. 32 South  Korea Neuromodulation Market, 2016-2026
        FIG. 33 South-East Asia Neuromodulation Market, 2016-2026
        FIG. 34 Rest of Asia Pacific Neuromodulation Market, 2016-2026
        FIG. 35 Latin America Neuromodulation Market, 2016-2026
        FIG. 36 Brazil Neuromodulation Market, 2016-2026
        FIG. 37 Mexico Neuromodulation Market, 2016-2026
        FIG. 38 Rest of Latin America Neuromodulation Market, 2016-2026
        FIG. 39 The Middle-East and Africa Neuromodulation Market, 2016-2026
        FIG. 40 GCC Countries Neuromodulation Market, 2016-2026
        FIG. 41 South Africa Neuromodulation Market, 2016-2026
        FIG. 42 Rest of Middle-East Africa Neuromodulation Market, 2016-2026
        FIG. 43 Competitor Market Share – Revenue
        FIG. 44 Boston Scientific Corporation Revenue and Growth Rate
        FIG. 45 Boston Scientific Corporation Market Share
        FIG. 46 Medtronic Revenue and Growth Rate
        FIG. 47 Medtronic Market Share
        FIG. 48 Abbott Revenue and Growth Rate
        FIG. 49 Abbott Market Share
        FIG. 50 Synapse Biomedical Inc. Revenue and Growth Rate
        FIG. 51 Synapse Biomedical Inc. Market Share
        FIG. 52 LivaNova Revenue and Growth Rate
        FIG. 53 LivaNova Market Share
        FIG. 54 Nevro Corporation Revenue and Growth Rate
        FIG. 55 Nevro Corporation Market Share
        FIG. 56 NeuroPace Revenue and Growth Rate
        FIG. 57 NeuroPace Market Share
        FIG. 58 NeuroSigma Revenue and Growth Rate
        FIG. 59 NeuroSigma Market Share
        FIG. 60 Neuronetics Revenue and Growth Rate
        FIG. 61 Neuronetics Market Share
        FIG. 62 BioControl Medical Revenue and Growth Rate
        FIG. 63 BioControl Medical Market Share
        FIG. 64 Market Dynamics
        FIG. 65 Global Neuromodulation – Value Chain Analysis
        FIG. 66 Technology Roadmap and Timeline
        FIG. 67 Market Attractiveness Analysis – By Technology
        FIG. 68 Market Attractiveness Analysis – By Application
        FIG. 69 Market Attractiveness Analysis – By Region
        FIG. 70 Market Channel
        FIG. 71 Marketing Channel Development Trend
        FIG. 72 Growth in World Gross Product, 2008-2018
        

        List of Tables

        TABLE 1 Global Neuromodulation Market, 2018 & 2025 (USD Billion)
        TABLE 2 Global Neuromodulation market, by Technology, 2016-2026 (USD Billion)
        TABLE 3 Global Neuromodulation market, by Application, 2016-2026 (USD Billion)
        TABLE 4 Global Neuromodulation market, by Region, 2016-2026 (USD Billion)
        TABLE 5 North America Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
        TABLE 6 North America Neuromodulation Market, by Application, 2016-2026 (USD Billion)
        TABLE 7 Europe Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
        TABLE 8 Europe Neuromodulation Market, by Application, 2016-2026 (USD Billion)
        TABLE 9 Asia Pacific Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
        TABLE 10 Asia Pacific Neuromodulation Market, by Application, 2016-2026 (USD Billion)
        TABLE 11 Latin America Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
        TABLE 12 Latin America Neuromodulation Market, by Application, 2016-2026 (USD Billion)
        TABLE 13 The Middle-East and Africa Neuromodulation Market, by Technology, 2016-2026 (USD Billion)
        TABLE 14 The Middle-East and Africa Neuromodulation Market, by Application, 2016-2026 (USD Billion)
        TABLE 15 Global Neuromodulation Market - Company Revenue Analysis 2016-2019 (USD Billion)
        TABLE 16 Global Neuromodulation Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities
        

Industry Major Market Players

  •  Boston Scientific Corporation
  •  Medtronic
  •  Abbott
  •  Synapse Biomedical Inc.
  •  LivaNova
  •  Nevro Corporation
  •  NeuroPace
  •  NeuroSigma
  •  Neuronetics
  •  BioControl Medical

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Neuromodulation Market.
According to Facts and Factors research report, the global Neuromodulation Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Neuromodulation Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Neuromodulation Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Neuromodulation Market in North America over coming decade.
key questions and why choose us

Related Reports

report img

Corporate Wellness Market

[205+ Pages Report] According to a Facts and Factors market research report, the globalcorporate wellness solutions market is projected to reach USD 100 Billion by 2026 from USD 61.3 Billion in 2020, at a CAGR of 8.5% during the forecast period. Global Corporate Wellness Market: Overview Corpo...

Published Date : 27-Sep-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Medical Polymers Market

[203+ Pages Report] According to a survey released by Facts and Factors, the globalmedical polymers market was valued at USD 16,500 Million in 2020 and is predicted to reach USD 28,290 Million by the end of 2026, rising at a CAGR of nearly 9.40% between 2021 and 2026. Global Medical Polymers Mar...

Published Date : 08-Sep-2021 | | Category : | Pages : 203 | Format : Read more

Inquiry for Buying Request Sample